Brief Report: Autism Spectrum Disorder: A Comprehensive Survey of Randomized Controlled Trials

Brief Report

Abstract

We searched the Cochrane Central Register of Controlled Trials to provide an overview of evidence from randomized controlled trials (RCTs) of therapeutic interventions for autism spectrum disorders. From the final survey (529 RCTs), the mean size was 49 participants (standard deviation 50, range 1–479, median 36, mode 40), with a sharp increase in the number of RCTs from 2008. The most frequently evaluated intervention was antipsychotic treatment (n = 44, 3006 participants). The journal with the most RCTs was the Journal of Autism and Developmental Disorders (N = 104). Most trials were small in size, emphasising the need for research groups to collaborate to generate higher quality data with greater applicability to clinical practice.

Keywords

Autism Autistic ASD Randomized Trials Survey 

Notes

Acknowledgments

The authors would like to thank the Cochrane Schizophrenia Group for the provision of data and library services.

Author Contributions

ST conceived of the study, participated in its design, led in its coordination and drafted the manuscript; CA conceived of the study, led in its design, participated in its coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Compliance with Ethical Standards

Conflict of interest

Samuel Tromans and Clive Adams declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

10803_2018_3569_MOESM1_ESM.xlsx (130 kb)
Supplementary material 1 (XLSX 129 KB)
10803_2018_3569_MOESM2_ESM.xlsx (114 kb)
Supplementary material 2 (XLSX 114 KB)

References

  1. Barnard, L., Young, A., Pearson, J., Geddes, J., & O’brien, G. (2002). A systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology, 16(1), 93–101.CrossRefPubMedGoogle Scholar
  2. Baxter, A., Brugha, T., Erskine, H., Scheurer, R., Vos, T., & Scott, J. (2015). The epidemiology and global burden of autism spectrum disorders. Psychological Medicine, 45(3), 601–613.CrossRefPubMedGoogle Scholar
  3. CENTRAL creation details (2014). Retrieved June 26, 2017 from http://www.cochranelibrary.com/help/central-creation-details.html.
  4. Chalmers, I., Bracken, M. B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A. M., et al. (2014). How to increase value and reduce waste when research priorities are set. The Lancet, 383(9912), 156–165.CrossRefGoogle Scholar
  5. Cooke, A., Smith, D., & Booth, A. (2012). Beyond PICO: The SPIDER tool for qualitative evidence synthesis. Qualitative Health Research, 22(10), 1435–1443.CrossRefPubMedGoogle Scholar
  6. Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A., & Veenstra-VanderWeele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130(4), 717–726.  https://doi.org/10.1542/peds.2012-0683.CrossRefPubMedPubMedCentralGoogle Scholar
  7. DSM-5 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing.CrossRefGoogle Scholar
  8. Falkmer, T., Anderson, K., Falkmer, M., & Horlin, C. (2013). Diagnostic procedures in autism spectrum disorders: A systematic literature review. European Child & Adolescent Psychiatry, 22(6), 329–340.CrossRefGoogle Scholar
  9. Gates, J. A., Kang, E., & Lerner, M. D. (2017). Efficacy of group social skills interventions for youth with autism spectrum disorder: A systematic review and meta-analysis. Clinical Psychology Review, 52, 164–181.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Huang, X., Lin, J., & Demner-Fushman, D. (2006). Evaluation of PICO as a knowledge representation for clinical questions. In AMIA annual symposium proceedings, pp. 359–363.Google Scholar
  11. Interagency Autism Coordinating Committee. (2017). 2016–2017 interagency autism coordinating committee strategic plan for autism spectrum disorder. Retrieved February 8, 2017 from https://iacc.hhs.gov/publications/strategic-plan/2017/.
  12. Jang, J., Matson, J. L., Williams, L. W., Tureck, K., Goldin, R. L., & Cervantes, P. E. (2013). Rates of comorbid symptoms in children with ASD, ADHD, and comorbid ASD and ADHD. Research in Developmental Disabilities, 34(8), 2369–2378.CrossRefPubMedGoogle Scholar
  13. Leon, A. C., Davis, L. L., & Kraemer, H. C. (2011). The role and interpretation of pilot studies in clinical research. Journal of Psychiatric Research, 45(5), 626–629.  https://doi.org/10.1016/j.jpsychires.2010.10.008.CrossRefPubMedGoogle Scholar
  14. McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., et al. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127(5), e1312–e1321.  https://doi.org/10.1542/peds.2011-0427.CrossRefPubMedGoogle Scholar
  15. Postorino, V., Sharp, W. G., McCracken, C. E., Bearss, K., Burrell, T. L., Evans, A. N., et al. (2017). A systematic review and meta-analysis of parent training for disruptive behavior in children with autism spectrum disorder. Clinical Child and Family Psychology Review, 20(4), 391–402.CrossRefPubMedGoogle Scholar
  16. Sathe, N., Andrews, J. C., McPheeters, M. L., & Warren, Z. E. (2017). Nutritional and dietary interventions for autism spectrum disorder: A. systematic review. Pediatrics.  https://doi.org/10.1542/peds.2017-0346.Google Scholar
  17. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Medicine, 8(1), 18.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Siegel, M., & Beaulieu, A. A. (2012). Psychotropic medications in children with autism spectrum disorders: A systematic review and synthesis for evidence-based practice. Journal of Autism and Developmental Disorders, 42(8), 1592–1605.CrossRefPubMedGoogle Scholar
  19. Trikalinos, T. A., Churchill, R., Ferri, M., Leucht, S., Tuunainen, A., Wahlbeck, K., et al. (2004). Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. Journal of Clinical Epidemiology, 57(11), 1124–1130.CrossRefPubMedGoogle Scholar
  20. U.S National Library of Medicine. (2018). ClinicalTrials.gov. Retrieved February 8, 2018 from https://clinicaltrials.gov/ct2/results?cond=Autism&term=&cntry=&stage=&city=&dist=.
  21. Weitlauf, A. S., Sathe, N., McPheeters, M. L., & Warren, Z. E. (2017). Interventions targeting sensory challenges in autism spectrum disorder: A systematic review. Pediatrics.  https://doi.org/10.1542/peds.2017-0347.PubMedGoogle Scholar
  22. Wessely, S. (2007). Randomised, controlled trials. In Choosing methods in mental health research: Mental health research from theory to practice (pp. 85–98). New York: Psychology Press.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Psychiatry of Intellectual Disability, Agnes UnitLeicestershire Partnership NHS TrustLeicesterUK
  2. 2.Department of Health SciencesUniversity of LeicesterLeicesterUK
  3. 3.Cochrane Schizophrenia Group, Institute of Mental HealthUniversity of NottinghamNottinghamUK

Personalised recommendations